mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.094 |
0.04 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.04 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.04 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.04 |
mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.04 |
mRNA |
AP-24534 |
GDSC1000 |
pan-cancer |
AAC |
0.068 |
0.04 |
mRNA |
QL-XII-47 |
GDSC1000 |
pan-cancer |
AAC |
-0.067 |
0.04 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.04 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.04 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.094 |
0.04 |